Articles
The reading room of Bioprocess Hub — a curated, continuously refreshed digest of the writing that matters across the bio-economy.
Every day we pull the latest long-form pieces from the sector's most respected blogs, trade journals and research outlets — Labiotech, Genetic Engineering News, Fierce Biotech, Fierce Pharma, Endpoints News, AgFunderNews, Green Queen, New Hope, ScienceDaily and the Good Food Institute — and distil each into a short, honest preview so you can decide what deserves your time. Coverage spans the full breadth of modern biomanufacturing: therapeutics and gene editing, cell and gene therapy, precision fermentation and alternative proteins, agricultural biologicals, the microbiome, upstream and downstream processing, and the funding rounds and national policies shaping where the industry goes next.
Nothing is paywalled or rewritten — every card links straight back to the original article at its source, giving those publishers full credit and you the complete story. Use the search box to track a topic — CAR-T, single-use bioreactors, India's BioE3 — or narrow the feed by sector, or by the country a story concerns. The filters build themselves from whatever is currently in the feed, so they always reflect the latest reading. It is the fastest way to stay fluent in an industry that moves quickly — check back often, because the collection grows every single day.
Upstream vs. Downstream Bioprocessing: The Big Picture
By Bioprocess Hub Admin · 8/21/2026
‘One of the fastest-growing CPG brands in America…’ David Protein owner hits $2.25bn valuation on $250m Series B
AgFunderNews · 9/4/2026Read original →
🎥 ‘The whole system is now more investable’: Reservoir makes the case for ag robotics
AgFunderNews · 8/29/2026Read original →
🎥 Carbon Robotics: $100m+ revenue, new machine and a path to IPO
AgFunderNews · 8/31/2026Read original →
🎥 From 2D images to 3D worlds: Bonsai bets on AI-powered farm robotics
AgFunderNews · 8/31/2026Read original →
🎥 Orchard Robotics CEO: Growers ‘shouldn’t have to be data analysts’
AgFunderNews · 9/2/2026Read original →
🎥 TRIC Robotics scales to 1,500 strawberry acres with 15-robot fleet
AgFunderNews · 9/1/2026Read original →
AgriFood Signals: EIF backs Nordic Foodtech VC, NotCo sells Brazilian business, Agronutris in receivership
AgFunderNews · 9/11/2026Read original →
AgriFood Signals: Farmbot unearths fresh funding, Homestead Capital nabs $150m, Gates backs ‘HeatSmart’ cassava
AgFunderNews · 8/21/2026Read original →
AgriFood Signals: Remembering Wendell Berry, Farmland LP’s new fund, Dairy Queen robots
AgFunderNews · 9/3/2026Read original →
AgriFood Signals: Reservoir & Deere partnership, 80 Acres Farms lawsuit, new blended finance for Africa
AgFunderNews · 8/28/2026Read original →
BREAKING: UPSIDE Foods terminates $50m bid for Believer Meats’ US site but “remains interested in the facility”
AgFunderNews · 8/24/2026Read original →
Builders VC and others back SweetAg’s bid to modernize the agricultural lending process
AgFunderNews · 9/7/2026Read original →
Can Culta take Japan’s premium fruit model global?
AgFunderNews · 9/14/2026Read original →
Can smarter surveillance help poultry farms catch bird flu earlier?
AgFunderNews · 8/25/2026Read original →
Century-old Keystone Cooperative joins Alloy Partners’ venture studio for animal, human and planetary health
AgFunderNews · 8/24/2026Read original →
CropX acquires NIR spectroscopy firm SCIO in biggest deal yet, eyes profitability in 2027
AgFunderNews · 8/26/2026Read original →
Digital ag platform xFarm Technologies expands to sugarcane, biofuels with Sibium Analytics acquisition
AgFunderNews · 9/15/2026Read original →
Exclusive: Ayana Bio acquires Meati Foods assets for a steal to scale plant cell culture tech with Zenfold in India
AgFunderNews · 9/15/2026Read original →
Exclusive: Plantd converts a construction waste problem into revenue with new biochar line
AgFunderNews · 8/28/2026Read original →
Facet Amtech bets on multifunctional catalyst to disrupt ammonia production
AgFunderNews · 8/26/2026Read original →
Formo scales precision-fermented casein ahead of US debut as narrative shifts from sustainability and ethics to performance
AgFunderNews · 9/16/2026Read original →
How AgFunder is using AI to build a venture firm that remembers
AgFunderNews · 9/11/2026Read original →
IIF to launch its farm investment platform across Canada following new capital raise from Verdex
AgFunderNews · 8/20/2026Read original →
In ovo sexing hits 40% penetration in the EU. What will it take to crack the US?
AgFunderNews · 9/9/2026Read original →
Knip bets on postbiotics, not commodity protein, as it scales biomass fermentation
AgFunderNews · 9/10/2026Read original →
Livestock management app Breedr plans expansion after $27m raise led by Partech’s impact arm
AgFunderNews · 8/27/2026Read original →
Mafix raises $5.4m to activate silicate rock into climate-smart fertilizer
AgFunderNews · 8/20/2026Read original →
MOA Foodtech nets $3.8m to scale AI-powered biomass fermentation platform
AgFunderNews · 9/3/2026Read original →
Natural Capital gaining ‘increasing recognition’ from more institutional investors: report
AgFunderNews · 8/21/2026Read original →
No, imaging won’t help farmers control plant disease
AgFunderNews · 9/11/2026Read original →
NoFence’s new herd management platform points to virtual fencing’s next chapter
AgFunderNews · 9/8/2026Read original →
Orbit Ventures on innovation theater, AI to turbocharge emerging markets, and the risks of Blitzscaling
AgFunderNews · 9/4/2026Read original →
ProducePay eyes profitability as it shifts from capital to data: ‘We think 2027 will be a breakout year’
AgFunderNews · 9/10/2026Read original →
TerraBlaster raises $12.5m for real time NPK soil mapping at tractor speed
AgFunderNews · 8/25/2026Read original →
With young farmers struggling, PepsiCo explores ways to keep agriculture ‘a viable and attractive livelihood’
AgFunderNews · 9/2/2026Read original →
#ESC26: Arrowhead claims safety edge over Ionis as triglyceride battle draws closer
Endpoints News · 8/30/2026Read original →
#ESC26: AstraZeneca's relaxin pill shows promise in mid-stage heart failure trial
Endpoints News · 8/30/2026Read original →
#ESC26: CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy
Endpoints News · 8/28/2026Read original →
#ESC26: Novartis pushes ahead with its IL-6 inhibitor despite Novo's failure
Endpoints News · 8/29/2026Read original →
AbbVie claims Phase 3 win for multiple myeloma drug etentamig
Endpoints News · 9/3/2026Read original →
AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic
Endpoints News · 9/5/2026Read original →
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
Endpoints News · 9/13/2026Read original →
Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug
Endpoints News · 9/11/2026Read original →
Amgen, academic centers weigh new FDA pilot to speed early drug trials
Endpoints News · 8/26/2026Read original →
Amgen’s T-cell engager notches major new lung cancer victory
Endpoints News · 9/8/2026Read original →
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
Endpoints News · 9/2/2026Read original →
ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease
Endpoints News · 9/9/2026Read original →
Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T
Endpoints News · 9/1/2026Read original →As Trump 2.0 targets federal research, a new study shows the stakes
Endpoints News · 8/21/2026Read original →
Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal
Endpoints News · 8/25/2026Read original →
Biohaven strikes $795M deal for commercial partner in epilepsy
Endpoints News · 8/26/2026Read original →
BioNTech says CTLA-4 drug nearly doubled survival times for lung cancer
Endpoints News · 9/14/2026Read original →
BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine
Endpoints News · 8/28/2026Read original →
CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more
Endpoints News · 9/5/2026Read original →
CBER official overruled review team's rejection of new Replimune melanoma drug
Endpoints News · 9/2/2026Read original →
Cellares rebukes Bristol Myers' criticism of its cell therapy technology
Endpoints News · 8/26/2026Read original →
Centric Compounding recalls three injectables over contamination
Endpoints News · 9/15/2026Read original →
Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train
Endpoints News · 8/21/2026Read original →
Claret says its latest fund will have larger focus on European life sciences
Endpoints News · 9/7/2026Read original →
Current heads of CBER, CDER snag permanent jobs
Endpoints News · 9/9/2026Read original →
DC judge rejects Merck’s IRA case more than three years after it was filed
Endpoints News · 8/24/2026Read original →
Drugmakers cooperate with House probe of China trial sites
Endpoints News · 9/17/2026Read original →
Encoded closes $275M Series F for Dravet syndrome drug
Endpoints News · 9/9/2026Read original →
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
Endpoints News · 9/7/2026Read original →
FDA approves first radioligand generic, setting up rivalry with Novartis
Endpoints News · 9/15/2026Read original →
FDA approves Jazz's Ziihera in frontline gastric cancer
Endpoints News · 8/25/2026Read original →
FDA approves Takeda, Protagonist drug for rare blood disorder
Endpoints News · 8/29/2026Read original →
FDA delays Capricor's deramiocel PDUFA date to review new data
Endpoints News · 8/24/2026Read original →
FDA extends review of Exelixis' colorectal cancer drug candidate
Endpoints News · 9/11/2026Read original →
FDA faces questions on 'America First' provisions in latest user fee agreement
Endpoints News · 9/16/2026Read original →
FDA leaders project enhanced scrutiny of foreign data
Endpoints News · 9/3/2026Read original →
FDA looks into reassessing criteria around rare disease trials, endpoint selection
Endpoints News · 9/14/2026Read original →
FDA should follow EMA's lead on drug rejection disclosures, researchers say
Endpoints News · 9/9/2026Read original →
FDA suggests regulatory flexibility for assessing psychedelics
Endpoints News · 9/10/2026Read original →
Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial
Endpoints News · 8/21/2026Read original →
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
Endpoints News · 8/28/2026Read original →
Gilead reaches HIV PrEP agreements; Hong Kong investigates Cloudbreak IPO
Endpoints News · 9/16/2026Read original →
GSK heads to FDA with recently acquired drug from Nuvalent
Endpoints News · 9/14/2026Read original →GSK to wind down German vaccine factory due to lack of demand
Endpoints News · 9/14/2026Read original →
Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns
Endpoints News · 8/26/2026Read original →
Health Tech meets AI giants
Endpoints News · 9/2/2026Read original →
How past Endpoints 11 winners fared as biotech industry rebounded
Endpoints News · 9/10/2026Read original →
Impacts of CMS’ GLP-1 pilot program begin to take shape
Endpoints News · 8/28/2026Read original →
Ionis wins FDA approval of Alexander disease drug zilganersen
Endpoints News · 9/4/2026Read original →
J&J’s Imaavy wins label expansion; Two approvals in Japan
Endpoints News · 8/25/2026Read original →
Key research behind orexin and narcolepsy wins Lasker Award
Endpoints News · 9/9/2026Read original →
Klomp, Warren spar over MFN deal contracts
Endpoints News · 9/16/2026Read original →
Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more
Endpoints News · 8/29/2026Read original →
Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026
Endpoints News · 8/31/2026Read original →
Lonza to build new US factory; Samsung Bio signs $262M contract
Endpoints News · 9/10/2026Read original →
MassBio report details challenges spanning China, NIH
Endpoints News · 8/26/2026Read original →
Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears
Endpoints News · 9/4/2026Read original →
Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug
Endpoints News · 8/28/2026Read original →
New report may spell trouble for future cheaper biologics
Endpoints News · 9/11/2026Read original →
Novartis CAR-T deaths raise questions over acceptable autoimmune risk
Endpoints News · 9/3/2026Read original →
Novartis' drug delivery deal with Alteogen; More worker cuts at Cellares
Endpoints News · 9/3/2026Read original →
Novartis' Phase 3 pelacarsen study miss raises the stakes for Amgen, Lilly
Endpoints News · 9/7/2026Read original →
Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data
Endpoints News · 9/3/2026Read original →
Pharma's legal battle over Medicare negotiations reaches 'dead end'
Endpoints News · 8/27/2026Read original →
Pharvaris' stock jumps on pivotal success in rare genetic disease
Endpoints News · 9/8/2026Read original →
Regenxbio hit with another clinical hold for Hunter syndrome gene therapy
Endpoints News · 8/24/2026Read original →
Researchers implant human neurons in mice brains to study disease
Endpoints News · 9/16/2026Read original →
RFK Jr. takes another step toward dismantling vaccine recommendations
Endpoints News · 8/21/2026Read original →
Roivant's dermatomyositis drug Lisraya snags FDA approval
Endpoints News · 8/28/2026Read original →
Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug
Endpoints News · 8/31/2026Read original →
Setbacks for Novartis; Anthropic looks for a dealmaker; and more
Endpoints News · 9/12/2026Read original →
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label
Endpoints News · 9/10/2026Read original →
Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis
Endpoints News · 9/15/2026Read original →
Sword Health plans to buy Headspace, filing says
Endpoints News · 8/26/2026Read original →
Take the Q3 Biopharma Sentiment Survey (BPSI)
Endpoints News · 8/31/2026Read original →
The race to make new Ebola vaccines faces a cash crunch
Endpoints News · 9/4/2026Read original →
Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets
Endpoints News · 9/4/2026Read original →
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
Endpoints News · 8/22/2026Read original →
Three takeaways from Trump's latest drug pricing event
Endpoints News · 9/1/2026Read original →
Trump announces nine new MFN drug pricing deals
Endpoints News · 9/1/2026Read original →
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
Endpoints News · 9/2/2026Read original →
Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility
Endpoints News · 9/7/2026Read original →
US-China biotech NeuShen gets $80M to develop brain-health drugs
Endpoints News · 9/4/2026Read original →
Why apps want your medical records
Endpoints News · 9/8/2026Read original →
Yarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trial
Endpoints News · 9/11/2026Read original →‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
Fierce Biotech · 9/1/2026Read original →A year on from Big Pharma’s pull-back from the UK, has anything changed?
Fierce Biotech · 9/7/2026Read original →AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies
Fierce Biotech · 9/8/2026Read original →Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
Fierce Biotech · 8/27/2026Read original →ArsenalBio sheds most of staff in pivot to in vivo CAR-T
Fierce Biotech · 9/2/2026Read original →AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond
Fierce Biotech · 8/31/2026Read original →AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
Fierce Biotech · 9/9/2026Read original →Biohaven epilepsy drug suffers FDA hold days after attracting $350M deal
Fierce Biotech · 9/11/2026Read original →BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
Fierce Biotech · 8/31/2026Read original →Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
Fierce Biotech · 8/24/2026Read original →Boston Scientific cyberattack likely to have ‘material impact’ on financial results
Fierce Biotech · 9/9/2026Read original →CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
Fierce Biotech · 9/17/2026Read original →CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
Fierce Biotech · 8/28/2026Read original →Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
Fierce Biotech · 9/5/2026Read original →Chutes & Ladders—Neumora shuffles leadership ahead of IND
Fierce Biotech · 8/24/2026Read original →Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
Fierce Biotech · 9/15/2026Read original →Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
Fierce Biotech · 9/15/2026Read original →Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
Fierce Biotech · 9/1/2026Read original →ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM
Fierce Biotech · 9/2/2026Read original →FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
Fierce Biotech · 9/9/2026Read original →FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer
Fierce Biotech · 9/14/2026Read original →FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
Fierce Biotech · 8/27/2026Read original →FDA launches pilot program to speed up sluggish phase 1 trials
Fierce Biotech · 9/16/2026Read original →Fierce Biotech Fundraising Tracker '26: NeuShen nets $80M; Superluminal snags $60M
Fierce Biotech · 9/8/2026Read original →Fierce Biotech Layoff Tracker 2026: Sionna halves staff; Merck trims more NJ jobs
Fierce Biotech · 9/16/2026Read original →Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
Fierce Biotech · 9/3/2026Read original →Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal
Fierce Biotech · 8/26/2026Read original →Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs
Fierce Biotech · 9/11/2026Read original →GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times
Fierce Biotech · 9/14/2026Read original →GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
Fierce Biotech · 9/14/2026Read original →GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing
Fierce Biotech · 9/10/2026Read original →Implantica finally nabs FDA approval 8 years after EU green light for reflux implant
Fierce Biotech · 8/26/2026Read original →Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Fierce Biotech · 9/7/2026Read original →Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
Fierce Biotech · 9/13/2026Read original →J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
Fierce Biotech · 9/15/2026Read original →JATT mastermind launches latest biotech-focused SPAC via $60M IPO
Fierce Biotech · 8/27/2026Read original →Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapy
Fierce Biotech · 9/10/2026Read original →Labcorp launches new hepatitis D test to find patients with most severe form of virus
Fierce Biotech · 8/26/2026Read original →Lilly cans early experimental obesity drug after ‘high bar’ not met
Fierce Biotech · 9/15/2026Read original →Luma locks down 15-year, $410M fund for life science investments
Fierce Biotech · 9/10/2026Read original →Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'
Fierce Biotech · 9/11/2026Read original →Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
Fierce Biotech · 9/16/2026Read original →Medigen links up with Charles River in push to take enterovirus vaccine global
Fierce Biotech · 8/27/2026Read original →Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule
Fierce Biotech · 9/2/2026Read original →Menarini signs $771M deal to take Gan & Lee GLP-1 to European market
Fierce Biotech · 9/7/2026Read original →Natera teams with Angiex on cancer drug trial monitoring
Fierce Biotech · 9/1/2026Read original →Newly formed Jaguar acquires Afib device assets from J&J
Fierce Biotech · 9/16/2026Read original →Novartis ends ALS program after phase 2 flop, adding to R&D woes
Fierce Biotech · 9/17/2026Read original →Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
Fierce Biotech · 9/8/2026Read original →Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
Fierce Biotech · 9/17/2026Read original →Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
Fierce Biotech · 9/11/2026Read original →Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland
Fierce Biotech · 9/3/2026Read original →Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events
Fierce Biotech · 9/1/2026Read original →Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Fierce Biotech · 9/8/2026Read original →Osivax bags flu vaccine rights to pursue combination shot vision
Fierce Biotech · 8/28/2026Read original →Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal
Fierce Biotech · 9/4/2026Read original →Psilocybin proves promising in neuropathic pain mouse study
Fierce Biotech · 9/4/2026Read original →Qiagen appoints new chief executive after 9-month search
Fierce Biotech · 8/25/2026Read original →Research into protein interactions sheds new light on causes of autism
Fierce Biotech · 8/28/2026Read original →Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
Fierce Biotech · 9/2/2026Read original →Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test
Fierce Biotech · 8/25/2026Read original →Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'
Fierce Biotech · 9/12/2026Read original →Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
Fierce Biotech · 9/17/2026Read original →Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
Fierce Biotech · 8/25/2026Read original →Spyre's 3-pronged IBD strategy on track as IL-23 antibody rounds off trio of phase 2 wins
Fierce Biotech · 9/9/2026Read original →Teva autoimmune antibody notches ph. 2 win in celiac disease
Fierce Biotech · 9/3/2026Read original →Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
Fierce Biotech · 8/31/2026Read original →The future of RAS inhibitors
Fierce Biotech · 9/14/2026Read original →TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion
Fierce Biotech · 8/25/2026Read original →Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
Fierce Biotech · 9/10/2026Read original →Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug
Fierce Biotech · 8/24/2026Read original →Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'
Fierce Biotech · 8/26/2026Read original →Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
Fierce Biotech · 8/24/2026Read original →Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data
Fierce Biotech · 9/4/2026Read original →With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
Fierce Biotech · 8/28/2026Read original →AbbVie chips in for neurology advocacy through PGA Tour birdie campaign
Fierce Pharma · 9/16/2026Read original →AbbVie lines up Qulipta expansion with phase 3 win in untapped menstrual migraine indication
Fierce Pharma · 9/11/2026Read original →Actor Kevin Costner does the math in Caris Detect early cancer detection push
Fierce Pharma · 9/10/2026Read original →After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis
Fierce Pharma · 9/13/2026Read original →
After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations
Fierce Pharma · 8/25/2026Read original →Akeso, Summit’s ivonescimab tops Keytruda in lung cancer survival, with strong data in PD-L1-high patients
Fierce Pharma · 9/14/2026Read original →Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer
Fierce Pharma · 9/9/2026Read original →ARPA-H puts up $125M to bankroll personalized RNA-based drug production
Fierce Pharma · 9/3/2026Read original →As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground
Fierce Pharma · 8/28/2026Read original →Ascendis to pay 20% Yuviwel royalties in patent settlement with BioMarin
Fierce Pharma · 9/1/2026Read original →AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record
Fierce Pharma · 9/13/2026Read original →AZ leans on AI-generated llama to promote LAMA combo inhaler Breztri in new campaign
Fierce Pharma · 9/8/2026Read original →AZ, Daiichi's Enhertu scores long-awaited NICE blessing in HER2-low breast cancer
Fierce Pharma · 9/17/2026Read original →B. Braun adds to a string of IV solution recalls in US
Fierce Pharma · 9/1/2026Read original →Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3
Fierce Pharma · 8/26/2026Read original →Bausch + Lomb survey reveals low dry eye awareness for perimenopausal, postmenopausal women
Fierce Pharma · 9/2/2026Read original →Baxter issues recall of 2 products after particulate concerns resurface
Fierce Pharma · 8/27/2026Read original →Biogen enlists lupus patient advocate to share social media story of resilience
Fierce Pharma · 8/29/2026Read original →BioMarin drops Voxzogo development for Noonan syndrome as treatment landscape shifts
Fierce Pharma · 9/16/2026Read original →BioMarin pads case for Voxzogo expansion as achondroplasia competition field shifts
Fierce Pharma · 9/10/2026Read original →BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana
Fierce Pharma · 8/28/2026Read original →CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum
Fierce Pharma · 9/12/2026Read original →CDMO Lonza hones commercial focus with company vet's return to new role
Fierce Pharma · 9/1/2026Read original →Cellares downsizes New Jersey operations after losing BMS cell therapy contract
Fierce Pharma · 9/3/2026Read original →Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts
Fierce Pharma · 9/17/2026Read original →CMI boosts medical affairs capabilities with new specialty communications unit
Fierce Pharma · 9/4/2026Read original →Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns
Fierce Pharma · 9/8/2026Read original →Eight Trends Reshaping Patient-Centric Drug Development
Fierce Pharma · 9/9/2026Read original →ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM
Fierce Pharma · 8/31/2026Read original →FDA clears Bayer’s Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry
Fierce Pharma · 9/10/2026Read original →FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod
Fierce Pharma · 9/4/2026Read original →Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract
Fierce Pharma · 9/13/2026Read original →Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers
Fierce Pharma · 9/4/2026Read original →From Question to Action: Rethinking Pharma Engagement in the AI Era
Fierce Pharma · 9/8/2026Read original →Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet
Fierce Pharma · 8/28/2026Read original →GSK makes ‘difficult decision’ to shutter German flu vaccine manufacturing site
Fierce Pharma · 9/15/2026Read original →GSK prepares frontline FDA bid for Jideytro, its first lung cancer drug
Fierce Pharma · 9/14/2026Read original →
Hansa lays groundwork for Nasdaq debut ahead of US kidney transplant drug verdict
Fierce Pharma · 8/25/2026Read original →How is API Manufacturing Changing?
Fierce Pharma · 9/15/2026Read original →In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage
Fierce Pharma · 9/11/2026Read original →Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data
Fierce Pharma · 9/14/2026Read original →Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Fierce Pharma · 9/8/2026Read original →Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancer
Fierce Pharma · 8/26/2026Read original →Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients
Fierce Pharma · 8/31/2026Read original →
Lundbeck continues neuroscience evolution as CEO keeps company ‘punching above its weight’
Fierce Pharma · 8/24/2026Read original →McKesson strikes $2.25B deal to snap up Precision Medicine Group
Fierce Pharma · 8/26/2026Read original →Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative
Fierce Pharma · 9/10/2026Read original →
Merck, AZ lawsuits against Medicare price negotiations swatted down
Fierce Pharma · 8/25/2026Read original →Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results
Fierce Pharma · 9/14/2026Read original →MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
Fierce Pharma · 8/31/2026Read original →Novartis claims MS win as Rhapsido clears phase 3 with ‘no liver safety signal’
Fierce Pharma · 9/2/2026Read original →Novartis puts MS advocacy on the podium through social media partnership with British Olympian
Fierce Pharma · 9/4/2026Read original →Novo Nordisk’s Wegovy helps free 40% of kids from obesity in phase 3 trial
Fierce Pharma · 9/9/2026Read original →PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge
Fierce Pharma · 8/28/2026Read original →
Regulatory tracker: Another Tavneos domino falls as UK rescinds authorization
Fierce Pharma · 9/2/2026Read original →Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build
Fierce Pharma · 9/9/2026Read original →Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation
Fierce Pharma · 9/16/2026Read original →Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA
Fierce Pharma · 9/15/2026Read original →Shionogi taps The Bloc for omnichannel campaign backing COVID-19 pill Xocova
Fierce Pharma · 9/16/2026Read original →Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M
Fierce Pharma · 9/11/2026Read original →Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia vera
Fierce Pharma · 8/31/2026Read original →
The Oral GLP-1 Tracker: Novo's Wegovy pill, Lilly's Foundayo continue prescription climb
Fierce Pharma · 9/13/2026Read original →The people who stayed with the problem
Fierce Pharma · 9/7/2026Read original →Trialynx Wins DPHARM Idol Disrupt 2026
Fierce Pharma · 9/17/2026Read original →Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst
Fierce Pharma · 9/3/2026Read original →Vera’s strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry
Fierce Pharma · 9/17/2026Read original →
What did we learn from Big Pharma’s Q2 results?
Fierce Pharma · 8/24/2026Read original →White House unveils next round of MFN pricing deals with 9 midsized drugmakers
Fierce Pharma · 9/1/2026Read original →Why Earlier Commercial Involvement Drives Smarter Strategy
Fierce Pharma · 9/15/2026Read original →
‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer
GEN · 8/31/2026Read original →
ADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them All
GEN · 9/9/2026Read original →
Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples
GEN · 9/2/2026Read original →
AI Drug Discovery Hits a New Bottleneck: Experimental Validation
GEN · 9/9/2026Read original →
Ancient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New Antibiotics
GEN · 8/27/2026Read original →
Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy
GEN · 9/2/2026Read original →
Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer
GEN · 8/27/2026Read original →
Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior
GEN · 9/12/2026Read original →
Brain Protein in Mice Offers Insights Into Brain Development and ADHD
GEN · 9/17/2026Read original →
C. difficile Have Lasting Effects on the Infant Gut, Challenging Long-Held Assumption
GEN · 9/4/2026Read original →
Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies
GEN · 9/4/2026Read original →
CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial
GEN · 8/28/2026Read original →
Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01
GEN · 9/16/2026Read original →
Chronic Interferon Exposure Linked to Immunosuppression in Cancer
GEN · 9/11/2026Read original →
CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice
GEN · 9/11/2026Read original →
Consolidating Antibody Discovery Data with an AI Platform
GEN · 9/15/2026Read original →
Converted Human Pancreatic Duct Cells Show Diabetes Therapy Potential
GEN · 9/2/2026Read original →
DANDELION Computational Tool Identifies Previously Unknown Asthma-Related Genes and Pathway
GEN · 8/21/2026Read original →
Evonik Expands in Slovakia
GEN · 9/15/2026Read original →
Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles
GEN · 9/16/2026Read original →
Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations
GEN · 8/25/2026Read original →
Extracellular Secretion System Could Solve Industry Endonuclease Production Challenges
GEN · 8/26/2026Read original →
Five-Year Brain Organoids Reveal New Insights Into Human Development
GEN · 8/21/2026Read original →
From Images to Data
GEN · 8/28/2026Read original →
From Models to Agents: The Next Phase of AI Adoption in Molecular Discovery
GEN · 8/21/2026Read original →
Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model
GEN · 9/9/2026Read original →
Genetic Toolkit Isolates Neuron Types in Drosophila Brain
GEN · 8/28/2026Read original →
GLP-1 Drug Semaglutide Slows Aging and Extends Lifespan in Mice
GEN · 9/3/2026Read original →
Immune Cells Driving Alzheimer’s-Like Neurodegeneration Traced to Lymph Nodes
GEN · 9/4/2026Read original →
In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas
GEN · 8/26/2026Read original →
Increasing CHO Cell Productivity
GEN · 9/9/2026Read original →
Inhaled Suppressor tRNA Restores Gene Function in Cystic Fibrosis Models
GEN · 8/27/2026Read original →
Key Immune Cells Identified That Could Strengthen Flu Vaccines
GEN · 8/31/2026Read original →
Lab-Grown Neocortex Models Mimic Early Brain Organization
GEN · 8/21/2026Read original →
Male Sex Hormones Suppress Lung Allergies by Acting on Neurons in Mice
GEN · 8/24/2026Read original →
Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program
GEN · 9/10/2026Read original →
Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases
GEN · 9/4/2026Read original →
Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs
GEN · 9/4/2026Read original →
Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified
GEN · 8/28/2026Read original →
Monoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic Mice
GEN · 9/9/2026Read original →
Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage
GEN · 8/26/2026Read original →
Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era
GEN · 9/3/2026Read original →
Neural Mechanism Identified That Drives Increased Alcohol Use in Isolated Male Mice
GEN · 8/25/2026Read original →
New Cytometry Technique for Characterizing Viral Vectors
GEN · 8/26/2026Read original →
New Spectrometry Technique Could Aid Formulation Development
GEN · 9/2/2026Read original →
NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy
GEN · 9/5/2026Read original →
Notch Signaling Switch Enables Scalable Helper T Cell Production for CAR T
GEN · 8/28/2026Read original →
NRAS Mutations May Require Mutation-Guided Combination Therapies
GEN · 9/9/2026Read original →
One Standard, Multiple Platforms: ICH Q2(R2) Qualification of Host Cell Protein Analysis by LC–MS/MS
GEN · 8/25/2026Read original →
PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models
GEN · 8/25/2026Read original →
PD-L2 Blockade May Reduce Harmful Aging Cell Buildup
GEN · 9/11/2026Read original →
Pneumococcal Subtypes Influence the Impact of Air Pollution on Disease Risk
GEN · 9/14/2026Read original →
Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration
GEN · 9/16/2026Read original →
Prophylactic Phage Therapy Protects Mice Against Oral Salmonella Infection
GEN · 9/17/2026Read original →
Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice
GEN · 9/3/2026Read original →
Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies
GEN · 9/15/2026Read original →
Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development
GEN · 8/24/2026Read original →
Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm
GEN · 9/11/2026Read original →
Single-Cell Striatum Atlas Reveals Neurological Disorder Vulnerabilities
GEN · 9/2/2026Read original →
Single-Use Comes of Age—What Comes Next?
GEN · 9/1/2026Read original →
Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability
GEN · 8/25/2026Read original →
Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response
GEN · 9/1/2026Read original →
StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too
GEN · 8/23/2026Read original →
StockWatch: Novartis Loses More than Market Value After Phase III Failure
GEN · 9/14/2026Read original →
StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy
GEN · 8/30/2026Read original →
The Analytical Blueprint for Cell & Gene Therapy Success
GEN · 9/3/2026Read original →
The Emerging Power of Mass Spectrometry in Oncology
GEN · 9/10/2026Read original →
The Multi-Attribute Method (MAM) as a Biologics Lifecycle Backbone
GEN · 9/9/2026Read original →
TraceIQ Launched to Maximize Pharmaceutical Traceability
GEN · 9/2/2026Read original →
Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology
GEN · 9/11/2026Read original →
UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies
GEN · 8/27/2026Read original →
What 25 Years of Research Have Revealed About 9/11’s Long-Term Health Effects
GEN · 9/11/2026Read original →
Why Does a Particular Genetic Variant Lead to Accelerated Huntington Disease Development?
GEN · 9/14/2026Read original →
Building an alt protein community at Brown University and beyond
Good Food Institute · 5/22/2026Read original →
Germany’s High-Tech Agenda: innovation hub for alternative proteins could support economic growth
Good Food Institute · 5/21/2026Read original →
The Alt Protein Project welcomes 15 new student groups
Good Food Institute · 8/11/2026Read original →
The future of food is being decided now
Good Food Institute · 5/20/2026Read original →
‘Hot Girl Soda’: Female-Founded Feisty Bags Funding for Fizzy Plant Protein Drinks
Green Queen · 9/9/2026Read original →
ADM Gets $2.2M Award from Iowa State to Expand Precision Fermentation Capacity in Clinton
Green Queen · 8/24/2026Read original →
Äio, TFTAK Get $2.6M from Estonian Govt to Enhance Waste-Fermented Yeast Fat Production
Green Queen · 8/28/2026Read original →
Äio, Tilk Launch Skin-Boosting Face Cream with Two Waste-Fermented Yeast Fats
Green Queen · 9/11/2026Read original →
Alpro Launches Greek-Style Yoghurt Prioritising ‘Extra Creamy’ Texture Over Protein
Green Queen · 9/1/2026Read original →
Australia’s OMG Group Nabs Fresh Funding to Help Expand Protein Oat Milk Line
Green Queen · 9/3/2026Read original →
Belgium’s Maash Brews Up $14M in Funding to Fuel Industrial-Scale Mycoprotein Production
Green Queen · 8/27/2026Read original →
Believe in Tempeh, Not Chicken: Better Nature Takes on KFC As Brits Seek New Protein Options
Green Queen · 9/10/2026Read original →
Beyond Meat Brings Plant Protein Drinks to California with Erewhon Launch
Green Queen · 8/25/2026Read original →
Beyond Meat Debuts Whole-Cut Mycelium Steak Filet at Erewhon
Green Queen · 9/16/2026Read original →
Beyond Meat Taps NHS Doctor & TV Fitness Influencer for UK Healthy Eating Campaign
Green Queen · 8/26/2026Read original →
Beyond Taste or Health, Plant-Based Meat Faces Barriers from Nostalgia & Cultural Traditions
Green Queen · 8/21/2026Read original →
Brazilian Researchers File Patent for Waste-Fermented Aromas to Enhance Plant-Based Meat
Green Queen · 8/25/2026Read original →
Burger King Debuts Plant-Based Crispy Chicken Burger in Austria
Green Queen · 9/9/2026Read original →
Canada’s Yves Veggie Cuisine ‘Back By Popular Demand’ with Maple Leaf Foods Acquisition
Green Queen · 9/15/2026Read original →
Christina Tosi’s Milk Bar Debuts Beyond Meat Dishes to Meet ‘Plant-Forward’ Demand
Green Queen · 8/27/2026Read original →
Dutch Govt Urged to Develop National Plant-Based Strategy with €65M Annual Fund
Green Queen · 9/14/2026Read original →
EU Research Strategy Ignores Funding for Alternative Protein Despite Scale-Up Goals
Green Queen · 9/14/2026Read original →
EU-Backed Startup Develops Superior Cultivated Meat Inputs That Could Benefit GLP-1 Users
Green Queen · 8/28/2026Read original →
Europe’s Alternative Protein Sector Sees 56% Bump in Funding in 2026
Green Queen · 8/31/2026Read original →
Fewer Americans Consider Processing Levels Before Buying Food, Shows Survey
Green Queen · 9/7/2026Read original →
Freezing Lentils Can Unlock Meat-Like Fibrous Textures with Minimal Processing
Green Queen · 9/7/2026Read original →
French Govt Invests €3.7M in Nūmi to Scale Up Cell-Cultured Breast Milk
Green Queen · 9/2/2026Read original →
Future Food Quick Bites: Alpro x McDonald’s, Leon Shiitake Burger & Vegan Hospitality
Green Queen · 9/2/2026Read original →
Future Food Quick Bites: Better Nature Tempeh, Protein Cereals & Vegan-Friendly Bundesliga
Green Queen · 8/26/2026Read original →
Future Food Quick Bites: Horchata Creamer, Cultivated Pet Food & Blended Meat in NYC
Green Queen · 9/9/2026Read original →
Future Food Quick Bites: Indian Protein Toppers, Planted at Starbucks & Google x Mitti Labs
Green Queen · 9/16/2026Read original →
Fysh Foods: Beyond Sushi Owner Scoops Up Shark Tank’s Influencer-Led Vegan Seafood Brand
Green Queen · 9/1/2026Read original →
GLP-1 Users Plan to Spend More on Protein & Fibre – Can Food Companies Capitalise?
Green Queen · 9/3/2026Read original →
Going Ham: EU Lawmakers Seek to Expand Scope of ‘Veggie Burger’ Labelling Ban
Green Queen · 8/27/2026Read original →
High-Protein, High-Fibre: Daring Foods Drops Frozen Skillet Meals with Plant-Based Chicken
Green Queen · 9/1/2026Read original →
Humble Edition: Planet Oat Releases Five-Ingredient Oat Milk with Banana Purée
Green Queen · 9/2/2026Read original →
Indian State-Backed Hub Develops Six Plant-Based Protein Bars from Local Pulses
Green Queen · 9/11/2026Read original →
Japan’s Aeon Taps Fuji Oil to Expand Cocoa-Free Chocolate Line
Green Queen · 9/15/2026Read original →
Loacker Teams Up with Endless Food Co to Support Bean-Free Chocolate Development
Green Queen · 9/16/2026Read original →
Microalgae Grown from Cultivated Meat Waste Could Cut Costs for Cell-Cultured Proteins
Green Queen · 8/24/2026Read original →
MOA Foodtech Raises $3.8M to Expand AI-Led, Waste-Fermented Egg Substitute & Yeast Enhancer
Green Queen · 9/3/2026Read original →
Mushroom Squared Goes Beyond Plant-Based Meat to Offer Wellness-Minded Functional Proteins
Green Queen · 9/7/2026Read original →
NFL Alumni Partners With Sweet Protein Maker Oobli to Promote Healthier Sugar Alternatives
Green Queen · 9/10/2026Read original →
NotCo Sells Brazilian Business & Reportedly Closes Mexican Arm Amid AI Pivot
Green Queen · 9/9/2026Read original →
Nourish Ingredients Signs European Manufacturing Deal to Scale Up Animal-Free Dairy Fat
Green Queen · 9/8/2026Read original →
Novel Food Firms Pausing UK Plans As EU Trade Deal Fuels Regulatory Uncertainty
Green Queen · 9/14/2026Read original →
Oatly Calls on Food Industry to Remove Barriers to Sustainable Consumer Choices
Green Queen · 9/16/2026Read original →
Oatly Opens Immersive Matcha Pop-Up Ahead of London Fashion Week
Green Queen · 9/4/2026Read original →
Oatly’s New Packaging Spotlights Public Clamour for Governments to Tackle Climate Change
Green Queen · 8/31/2026Read original →
Onego Bio Brings Animal-Free Egg Protein to Breakfast Category with Zen Waffles
Green Queen · 9/10/2026Read original →
OtherKinds: Koppie Unveils Consumer Brand for Pea-Based Beanless Coffee Drinks
Green Queen · 9/1/2026Read original →
Paleo Bags $2.3M to Advance Regulatory Filings for Animal-Free Meat Protein
Green Queen · 9/2/2026Read original →
Plant-Based Alternatives Now Up to 30% Cheaper Than Meat & Dairy in Dutch Supermarkets
Green Queen · 8/21/2026Read original →
Plant-Based Wellness Pioneer Organic Traditions Bags $10.5M to Plug North America’s Fibre Gap
Green Queen · 8/25/2026Read original →
Plenish Introduces Four-Ingredient Protein Oat Milk Fit for the UK’s Clean-Label Era
Green Queen · 9/3/2026Read original →
Revo Foods Turns Apricot Kernels Into Protein-Packed Dairy-Free Cottage Cheese
Green Queen · 9/8/2026Read original →
Rosewood Hotels & Resorts to Expand Plant-Based Menu Options in Thailand
Green Queen · 8/21/2026Read original →
SaladStop Pledges to Source 60% of Protein from Plant-Based Food Globally
Green Queen · 8/28/2026Read original →
Soglowek Acquires 70% Stake in Thai Meat-Free Manufacturer Plant & Bean
Green Queen · 8/21/2026Read original →
Steakholder Foods Rolls Out 3D-Printed Whole-Cut Meat at US Supermarkets
Green Queen · 9/4/2026Read original →
Symplicity Centres Fermented Vegetables in Nut Roast As Brits Embrace Whole Foods
Green Queen · 9/11/2026Read original →
Symplicity Centres Fermented Vegetables in Plant-Based Roast As Brits Embrace Whole Foods
Green Queen · 9/11/2026Read original →
The Phytosphere: Why Beyond Meat Launched Plant-Based Protein Powders, Jerky & Veggie Burgers
Green Queen · 9/10/2026Read original →
This Hong Kong Future Lab Was Made Using Recycled Plastic Bottles
Green Queen · 9/4/2026Read original →
Time-Travelling Milkman Rebrands to TTM Ingredients As Next-Gen Sunflower Fat Expands Horizons
Green Queen · 8/24/2026Read original →
Tofu Named the ‘Best Source of Protein’ Across Health & Climate Metrics
Green Queen · 8/24/2026Read original →
Trump’s Beef Tariff Plan Protects the Largest Driver of Global Deforestation
Green Queen · 9/4/2026Read original →
UK Makes Beans Compulsory & Adds Fortified Pea Milk to School Food Menus
Green Queen · 9/15/2026Read original →
UK Scientists Use AI to Identify Nearly 800 Plant Proteins for Sustainable Food
Green Queen · 9/8/2026Read original →
Ulrick + Short’s Sunflower Seed Flour Boosts Protein, Fibre & Texture Profile of Plant-Based Foods
Green Queen · 9/11/2026Read original →
Upside Foods Withdraws $50M Bid to Buy Believer Meats’s US Facility, But Retains Interest
Green Queen · 8/26/2026Read original →
US Vegan Seafood Maker Impact Food Winds Down As Meat-Eating Culture Persists
Green Queen · 8/31/2026Read original →
Veg-Led Food & Plant-Based Alternatives Can Coexist, Says Redefine Meat After Doubling UK Footprint
Green Queen · 9/8/2026Read original →
Voyage Foods Exits Retail to Boost Commercial Supply of Bean-Free Coffee, Chocolate & More
Green Queen · 9/14/2026Read original →
Yoga Bar Founder, Better Bite Ventures Launch $260,000 Scheme for Next-Gen Food Startups in India
Green Queen · 9/15/2026Read original →
Your Future Cookies Could Be Made from Upcycled Plastic Bottles
Green Queen · 8/25/2026Read original →Amylin analogs in the clinic: a deep dive
Labiotech · 8/24/2026Read original →Beyond biology: Nanobiotix’s physics-first approach to cancer
Labiotech · 8/21/2026Read original →Beyond Ozempic: the GLP-1 landscape in 2026
Labiotech · 9/14/2026Read original →BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event
Labiotech · 8/18/2026Read original →BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Labiotech · 8/28/2026Read original →BIOSPAIN 2026: Spain’s flagship biotech event is going annual
Labiotech · 9/15/2026Read original →Bladder cancer treatment: where are we standing in 2026?
Labiotech · 9/2/2026Read original →Charcot-Marie-Tooth disease: can medicines make it past clinical trials?
Labiotech · 8/26/2026Read original →Could your microbial process be stronger? Uncovering opportunities before scale-up and commercialization
Labiotech · 8/25/2026Read original →Eli Lilly’s pipeline in 2026: how the incretin boom is funding what comes next
Labiotech · 9/9/2026Read original →
ESC 2026: The drug development readouts that stood out
Labiotech · 9/1/2026Read original →Genomes to bioreactors: Saudi Arabia’s gene editing oncology push
Labiotech · 8/27/2026Read original →How AOCs are advancing targeted therapeutics
Labiotech · 8/31/2026Read original →How Evox Therapeutics is targeting CNS diseases with exosomes
Labiotech · 9/4/2026Read original →How human-first datasets are reshaping AI drug discovery
Labiotech · 6/25/2026Read original →Inside Takeda’s transformation: The pipeline strategy behind its next growth chapter
Labiotech · 7/14/2026Read original →Investor confidence is built beyond the data
Labiotech · 9/1/2026Read original →Life science industry in Geneva on a roll
Labiotech · 8/19/2026Read original →Navigating German biotech: 10 companies to keep an eye on in 2026
Labiotech · 9/15/2026Read original →New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?
Labiotech · 9/16/2026Read original →
NLS Days 2026: what’s dealmaking like in the Nordics?
Labiotech · 9/11/2026Read original →
Oncology biotech news: key moves to watch in September 2026
Labiotech · 9/16/2026Read original →Preclinical Pulse: The research catching our eye in September 2026
Labiotech · 9/9/2026Read original →Rethinking precision oncology drug development: AI and tumor biology for smarter therapeutic programs
Labiotech · 6/30/2026Read original →Rewriting the rules of genetic medicine with tRNA therapeutics
Labiotech · 9/11/2026Read original →Sanofi pipeline 2026: new leadership, same strategy?
Labiotech · 8/25/2026Read original →Six MASH biotech companies shaping the future of liver disease treatment
Labiotech · 8/28/2026Read original →Streamlining stable cell line development from the start
Labiotech · 9/8/2026Read original →The biggest biotech funding rounds in August 2026
Labiotech · 9/2/2026Read original →The cost of waiting: what licensing a biotech asset early really saves you
Labiotech · 8/21/2026Read original →
Top biotech deals in August 2026
Labiotech · 9/4/2026Read original →Unlocking cell & gene therapy performance: proven strategies for modern operations
Labiotech · 6/29/2026Read original →When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients
Labiotech · 9/7/2026Read original →
[Video] Mastering Channel Strategy: Thriving in a Complex, Competitive Market
New Hope · 9/2/2026Read original →
[Video] NBJ Practitioner Channel Data & Insights
New Hope · 9/4/2026Read original →
11 standout finds from Newtopia Now
New Hope · 9/1/2026Read original →
5 must-know trends that caught our editor's eye at Newtopia Now
New Hope · 8/31/2026Read original →
5 takeaways from Ulta Beauty's wellness strategy
New Hope · 9/11/2026Read original →
7 natural products brands pitch to investors at Newtopia Now
New Hope · 8/28/2026Read original →
Access NBJ Summit sessions on market data, changes in channel sales
New Hope · 9/4/2026Read original →
Analyst's Take: Why immunity supplements are reclaiming the wellness spotlight
New Hope · 9/11/2026Read original →
Announcing the 2026 Newtopia Now NEXTY Award finalists
New Hope · 8/26/2026Read original →
BARI looks beyond fruit purées with Asian-inspired baby foods
New Hope · 8/27/2026Read original →
Barilla Group to acquire Goodles mac and cheese, strengthening both portfolios
New Hope · 9/4/2026Read original →
Chef, noted restaurateur Giada de Laurentiis shares her journey into CPG
New Hope · 8/26/2026Read original →
Chobani invests $1.2B in Allentown, Penn., to create high-protein milk
New Hope · 9/2/2026Read original →
Dee Charlemagne teaches brands how to get on Walmart shelves
New Hope · 8/28/2026Read original →
Dry Storage elevates at-home baking with regenerative, organic flour
New Hope · 8/20/2026Read original →
Editor's Take: The natural products industry's $363B milestone reveals a channel revolution in progress
New Hope · 9/2/2026Read original →
Ferrero Group acquires Purely Elizabeth for $850M to expand breakfast, wellness portfolio
New Hope · 8/25/2026Read original →
Functional beverage The Cycle wins Newtopia Now's wellness pitch competition
New Hope · 8/24/2026Read original →
Gabby Reece's guide to an authentic life
New Hope · 8/25/2026Read original →
Hain Celestial to focus on North American brands, reducing debt after $323M sale
New Hope · 9/14/2026Read original →
How brands can fix hidden freight expenses that are quietly killing margins
New Hope · 8/27/2026Read original →
How independent retailers can avoid being an attractive target for online fraud
New Hope · 8/19/2026Read original →
How the manosphere is turning masculine anxiety into supplement sales
New Hope · 8/31/2026Read original →
How to make sense of the wall of shrooms
New Hope · 9/11/2026Read original →
Industry experts decode the big trends reshaping CPG
New Hope · 9/14/2026Read original →
Natural ingredients, clean-label certification drive health and beauty sales
New Hope · 9/7/2026Read original →
Natural Products Expo West 2027 speaker submissions close Sept. 24
New Hope · 9/14/2026Read original →
Nestle offloads Holistic Health platform for $1B
New Hope · 9/5/2026Read original →
Newtopia Now Connects 435+ Brands with Leading Retailers as Emerging CPG Innovation Takes Center Stage
New Hope · 8/27/2026Read original →
Newtopia Now embraces throwback trends honey, tea and bars
New Hope · 8/27/2026Read original →
Newtopia Now moves its 2027 chapter to Chicago
New Hope · 8/19/2026Read original →
Seed to Service event attendees donate 1,000 bags of produce to low-income families
New Hope · 9/15/2026Read original →
State of Natural Industry Snapshot Fall 2026
New Hope · 8/28/2026Read original →
Teddy's Tallow Chips taps into a hot trend
New Hope · 9/8/2026Read original →
The Natural List: Jessica Rubino's favorite baby products; the surprising power of CPG ecosystems
New Hope · 9/2/2026Read original →
The Natural List: New CPG trends from the Newtopia Now 2026 show floor
New Hope · 8/26/2026Read original →.jpg?disable=upscale&width=1200&height=630&fit=crop)
The Natural List: The peptide industry, explained
New Hope · 9/9/2026Read original →
The Natural List: Trust matters more than channel in retail strategy
New Hope · 9/16/2026Read original →
The NEXTY Awards return to Newtopia Now
New Hope · 8/24/2026Read original →
Tick-borne alpha-gal syndrome spreads fast, natural product solutions scarce
New Hope · 9/4/2026Read original →
Time for brands to move past the mycelium debate in functional mushrooms
New Hope · 9/10/2026Read original →.png?disable=upscale&width=1200&height=630&fit=crop)
What the Barilla x Goodles acquisition signals for the natural products industry
New Hope · 9/15/2026Read original →.png?width=720&quality=80&disable=upscale)
Will the U.S. go cold turkey on Big Ag?
New Hope · 8/20/2026Read original →
“One-in-a-million” sea creature fossil preserves soft tissue for 450 million years
ScienceDaily · 8/21/2026Read original →
324-million-year-old fossil reveals how insects conquered land
ScienceDaily · 8/27/2026Read original →
A hidden “on switch” in human DNA has finally been decoded
ScienceDaily · 8/23/2026Read original →Animals have been eating nature’s original bioplastic for millions of years
ScienceDaily · 8/17/2026Read original →
Japanese scientists use tiny silver particles to make DNA assembly up to 5x more efficient
ScienceDaily · 8/19/2026Read original →
Life uses 4 DNA letters. Scientists just made 8 work
ScienceDaily · 9/5/2026Read original →
MIT turns bacteria into living transistors
ScienceDaily · 9/4/2026Read original →
NASA finds Earth microbes could survive on the Moon
ScienceDaily · 8/25/2026Read original →
NASA-backed scientists turn plastic waste into edible cookies
ScienceDaily · 9/13/2026Read original →
Pollen has a surprising problem — and honeybees have found a way around it
ScienceDaily · 8/19/2026Read original →
Queen bees have a disturbing way to survive pesticides
ScienceDaily · 8/22/2026Read original →
Researchers unveil sustainable spirulina solution to vitamin B12 deficiency
ScienceDaily · 8/30/2026Read original →
Scientists discover a powerful new antivenom hidden in rattlesnake blood
ScienceDaily · 9/8/2026Read original →
Scientists finally see DNA “zip” itself together for the first time
ScienceDaily · 9/10/2026Read original →
Stanford scientists discover a seafood that can reverse signs of aging
ScienceDaily · 9/4/2026Read original →
The secret to longer life may be hidden in bat DNA
ScienceDaily · 9/12/2026Read original →